Mutant IDH Inhibitors Induce Lineage Differentiation in IDH-mutant Oligodendroglioma
Avishay Spitzer, Simon Gritsch, Hannah R. Weisman, L. Nicolas Gonzalez Castro, Masashi Nomura, Nicholas Druck, Rony Chanoch-Myers, Christine K. Lee, Hiroaki Nagashima, Julie J. Miller, Isabel Arrillaga-Romany, David N. Louis, Hiroaki Wakimoto, Will Pisano, Patrick Y. Wen, Keith L. Ligon, Daniel P. Cahill, Mario L. Suvà, Itay Tirosh
doi: https://doi.org/10.1101/2021.11.16.21266364
Avishay Spitzer
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel
Simon Gritsch
2Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
3Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
Hannah R. Weisman
2Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
3Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
L. Nicolas Gonzalez Castro
2Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
3Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
5Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA
Masashi Nomura
2Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
3Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
Nicholas Druck
2Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
3Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
Rony Chanoch-Myers
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel
Christine K. Lee
4Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA
Hiroaki Nagashima
4Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA
Julie J. Miller
5Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA
Isabel Arrillaga-Romany
5Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA
David N. Louis
2Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
Hiroaki Wakimoto
4Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA
Will Pisano
6Department of Pathology, Brigham and Women’s Hospital, Boston, MA
Patrick Y. Wen
7Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02114, USA
Keith L. Ligon
6Department of Pathology, Brigham and Women’s Hospital, Boston, MA
Daniel P. Cahill
4Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA
Mario L. Suvà
2Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
3Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
Itay Tirosh
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel
Data Availability
All data for untreated patients produced in the present study are available upon reasonable request to the authors. All data for IDHi-treated patients produced in the present study will be made available at a later time.
Posted November 20, 2021.
Mutant IDH Inhibitors Induce Lineage Differentiation in IDH-mutant Oligodendroglioma
Avishay Spitzer, Simon Gritsch, Hannah R. Weisman, L. Nicolas Gonzalez Castro, Masashi Nomura, Nicholas Druck, Rony Chanoch-Myers, Christine K. Lee, Hiroaki Nagashima, Julie J. Miller, Isabel Arrillaga-Romany, David N. Louis, Hiroaki Wakimoto, Will Pisano, Patrick Y. Wen, Keith L. Ligon, Daniel P. Cahill, Mario L. Suvà, Itay Tirosh
medRxiv 2021.11.16.21266364; doi: https://doi.org/10.1101/2021.11.16.21266364
Mutant IDH Inhibitors Induce Lineage Differentiation in IDH-mutant Oligodendroglioma
Avishay Spitzer, Simon Gritsch, Hannah R. Weisman, L. Nicolas Gonzalez Castro, Masashi Nomura, Nicholas Druck, Rony Chanoch-Myers, Christine K. Lee, Hiroaki Nagashima, Julie J. Miller, Isabel Arrillaga-Romany, David N. Louis, Hiroaki Wakimoto, Will Pisano, Patrick Y. Wen, Keith L. Ligon, Daniel P. Cahill, Mario L. Suvà, Itay Tirosh
medRxiv 2021.11.16.21266364; doi: https://doi.org/10.1101/2021.11.16.21266364
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)